Investor List:

Top Medical Devices Series A Investors in New York City (95)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Thilo Semmelbauer, Managing Director at Insight Partners
Thilo Semmelbauer
Insight Partners·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Photo of Peter Steinberg, General Partner at Gaingels
Peter Steinberg
Gaingels·General Partner
Sweet spot: $350K
Range: $200K - $500K
Investors in New York City
Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Education (Series A), Investors in Education (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Series A), Investors in FinTech (Series A), Investors in SaaS (Series A), Investors in Education (Series A), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Consumer Internet (Series A), Investors in FinTech (Seed), Investors in Education (Seed), Investors in BioTech (Series A), Investors in Consumer Internet (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Consumer Internet (Series A), Investors in FinTech (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Consumer Internet (Seed), Investors in New York City (Other Lists)
Photo of Alex Glassman, Vice President at Insight Partners
Alex Glassman
Insight Partners·Vice President
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in SaaS (Series B), Investors in SaaS (Series A), Investors in SaaS (Seed), Investors in New York City (Other Lists), Investors in SaaS (Series B), Investors in SaaS (Series A), Investors in SaaS (Seed)
Photo of Connor Guess, Vice President at Insight Partners
Connor Guess
Insight Partners·Vice President
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Photo of Shilpa Nayyar, Partner at FirstMark Capital
Shilpa Nayyar
Sweet spot: $5.0M
Range: $250K - $10.0M
Investors in New York (NY)
Photo of Steve Kraus, Partner at Bessemer Venture Partners
Steve Kraus
Sweet spot: $25.0M
Range: $1M - $250.0M
Investors in Boston / New England, Investors in New York (NY), Investors in Boston (MA)
Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Health IT (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series B), Investors in Digital Health (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists)
Photo of Marc Baum, Investor at Gaingels
Marc Baum
Gaingels·Investor
Sweet spot: $350K
Range: $200K - $500K
Investors in New York (NY)
Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series A), Investors in Education (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Education (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in AI (Series A), Investors in Education (Series A), Investors in AI (Seed), Investors in FinTech (Series A), Investors in SaaS (Series A), Investors in Education (Seed), Investors in SaaS (Seed), Investors in Consumer Health (Series A), Investors in Consumer Internet (Series A), Investors in Consumer Health (Seed), Investors in FinTech (Seed), Investors in Consumer Internet (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in AI (Series A), Investors in SaaS (Series A), Investors in AI (Seed), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in SaaS (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in New York City (Other Lists)
Photo of Carl  Gordon, Managing Partner at OrbiMed
Carl Gordon
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)